These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 24180669)
1. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium. Rubini G; Nicoletti A; Rubini D; Asabella AN Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669 [TBL] [Abstract][Full Text] [Related]
2. Radium-223 dichloride in clinical practice: a review. Florimonte L; Dellavedova L; Maffioli LS Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689 [TBL] [Abstract][Full Text] [Related]
3. The management of painful bone metastases with an emphasis on radionuclide therapy. Hillegonds DJ; Franklin S; Shelton DK; Vijayakumar S; Vijayakumar V J Natl Med Assoc; 2007 Jul; 99(7):785-94. PubMed ID: 17668645 [TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Bauman G; Charette M; Reid R; Sathya J Radiother Oncol; 2005 Jun; 75(3):258-70. PubMed ID: 16299924 [TBL] [Abstract][Full Text] [Related]
5. [Bone metastases treated with radiopharmaceuticals]. Giammarile F Bull Cancer; 2013 Nov; 100(11):1223-7. PubMed ID: 24409472 [TBL] [Abstract][Full Text] [Related]
6. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. Pandit-Taskar N; Batraki M; Divgi CR J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062 [TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review. Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636 [TBL] [Abstract][Full Text] [Related]
8. The use of radioisotopes for palliation of metastatic bone pain. Gkialas I; Iordanidou L; Galanakis I; Giannopoulos S J BUON; 2008; 13(2):177-83. PubMed ID: 18555462 [TBL] [Abstract][Full Text] [Related]
9. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?]. Badawi JK Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692 [TBL] [Abstract][Full Text] [Related]
10. Clinical dosimetry in the treatment of bone tumors: old and new agents. Hindorf C; Flux GD; Ibisch C; Kraeber Bodéré F Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):198-204. PubMed ID: 21386790 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods. Guerra Liberal FD; Tavares AA; Tavares JM Med Phys; 2014 Nov; 41(11):114101. PubMed ID: 25370676 [TBL] [Abstract][Full Text] [Related]
12. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride. Pandit-Taskar N; Larson SM; Carrasquillo JA J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987 [TBL] [Abstract][Full Text] [Related]
13. [Radionuclide therapy for bone metastases by drugs based on Re-188]. Liepe K; Krylov VV; Kochetova TY Vopr Onkol; 2016; 62(4):401-9. PubMed ID: 30474946 [TBL] [Abstract][Full Text] [Related]
14. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain. Paes FM; Serafini AN Semin Nucl Med; 2010 Mar; 40(2):89-104. PubMed ID: 20113678 [TBL] [Abstract][Full Text] [Related]
15. Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases. Lam MG; de Klerk JM; van Rijk PP; Zonnenberg BA Anticancer Agents Med Chem; 2007 Jul; 7(4):381-97. PubMed ID: 17630915 [TBL] [Abstract][Full Text] [Related]
16. 186Re-HEDP for metastatic bone pain in breast cancer patients. Lam MG; de Klerk JM; van Rijk PP Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846 [TBL] [Abstract][Full Text] [Related]
17. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium. Porter AT; Ben-Josef E; Davis L Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173 [TBL] [Abstract][Full Text] [Related]
18. [Targeted radionuclide therapy for castration-resistant prostate cancer]. Nakamura K; Ohga S; Sasaki T; Baba S; Honda H Nihon Rinsho; 2014 Dec; 72(12):2181-5. PubMed ID: 25518355 [TBL] [Abstract][Full Text] [Related]
19. Bone-targeting radiopharmaceuticals including radium-223. Brady D; Parker CC; O'Sullivan JM Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760 [TBL] [Abstract][Full Text] [Related]
20. Bone-targeted therapies to reduce skeletal morbidity in prostate cancer. Dorff TB; Agarwal N Asian J Androl; 2018; 20(3):215-220. PubMed ID: 29553053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]